Takayama, K., Takeshita, M., Inoue, K., Ichiki, M., Fujita, M., Harada, T., . . . Sugio, K. (2020). Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801. Oncologist.
Citación estilo ChicagoTakayama, Koichi, et al. "Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin Plus Maintenance Gemcitabine in Elderly Patients With Untreated Non‐Small Cell Lung Cancer: LOGIK0801." Oncologist 2020.
Cita MLATakayama, Koichi, et al. "Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin Plus Maintenance Gemcitabine in Elderly Patients With Untreated Non‐Small Cell Lung Cancer: LOGIK0801." Oncologist 2020.